<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> invading the submucosa but not the muscular layer (pT1, early <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e>) represents the earliest form of clinically relevant <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in most patients </plain></SENT>
<SENT sid="1" pm="."><plain>Neoplastic invasion of the submucosa, in fact, opens the way to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> via the lymphatic and blood vessels, and the choice between surveillance and major surgery will turn on its metastatic potential </plain></SENT>
<SENT sid="2" pm="."><plain>The following histological features predict the risk of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and the different clinical outcomes: grade of differentiation of <z:mp ids='MP_0002038'>carcinoma</z:mp>, lymphovascular invasion, state of the resection margin </plain></SENT>
<SENT sid="3" pm="."><plain>Microstaging of <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e>, namely the width and the depth of submucosal invasion, together with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding at the advancing edge allow the metastatic risk to be further stratified in minimal, low, and high </plain></SENT>
<SENT sid="4" pm="."><plain>Different, although morphologically undistinguishable, tumorigenic pathways are supposed to lead to the <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of colonic mucosa and subsequently to drive the progression from early to <z:e sem="disease" ids="C0877373" disease_type="Neoplastic Process" abbrv="">advanced cancer</z:e>: new biomarkers are needed to identify progressive and non-progressive pT1 <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>